In its current form, I am. The SPEAKER pro tempore. The Clerk will report the motion to recommit. The Clerk read as follows: Mr. Walden moves to recommit the bill H.R. 1425 to the Committee on Energy and Commerce with instructions to report the same back to the House forthwith with the following amendment: After section 2, insert the following: SEC. 3. EFFECTIVE DATE. This Act and the amendments made by this Act shall not take effect unless the Secretary of Health and Human Services, in consultation with the Commissioner of Food and Drugs, the Director of the National Institutes of Health, and the Director of the National Institute of Allergy and Infectious Diseases, certifies that no provision of this Act and the amendments made by this Act will adversely affect research on, development of, or approval of any drug (including any biological product) intended to treat or prevent infection with the virus that causes COVID-19. The SPEAKER pro tempore. Pursuant to the rule, the gentleman from Oregon is recognized for 5 minutes in support of his motion.
Share
More from Greg Walden
I don't believe I have any other speakers on my side of the aisle on this measure. I urge its passage, and I yield back the balance of my time.
I, too, rise in support of H.R. 4499, the National Institute on Minority and Health Disparities Research Endowment Revitalization Act. Mr. Speaker, I thank my Committee on Energy and Commerce colleagues on both sides of the aisle…
I do not have any more speakers on my side of the aisle on this matter. Mr. Speaker, I urge colleagues to approve the bill, and I yield back the balance of my time.
I want to make sure that it is a responsible way for all parties, which is why a number of us are very concerned about the administration's recent support of the waiver to release and transfer the IP for the vaccine.





